Continued cuts affect agencies that protect Americans from nuclear, chemical and biological threats
Agency is offering vouchers to some drug manufacturers to shorten review time for final drug applications
Terminations resulted in $1.81 billion in terminated grant funding; 30.0 percent had not been expended at time of termination
